742 related articles for article (PubMed ID: 19679483)
21. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
[TBL] [Abstract][Full Text] [Related]
23. Benzimidazole condensed ring systems. XII. Synthesis and anticancer evaluation of certain pyrido[1,2-a]benzimidazole derivatives.
el-Hawash SA; Badawey el-S A; Kappe T
Pharmazie; 1999 May; 54(5):341-6. PubMed ID: 10368827
[TBL] [Abstract][Full Text] [Related]
24. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
[TBL] [Abstract][Full Text] [Related]
25. Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Novellino E; Pepe S
J Med Chem; 2006 Aug; 49(17):5110-8. PubMed ID: 16913700
[TBL] [Abstract][Full Text] [Related]
26. 5-Substituted [1]pyrindine derivatives with antiproliferative activity.
Kolb S; Goddard ML; Loukaci A; Mondésert O; Ducommun B; Braud E; Garbay C
Eur J Med Chem; 2010 Mar; 45(3):896-901. PubMed ID: 19969400
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.
Rostom SA; Hassan GS; El-Subbagh HI
Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673
[TBL] [Abstract][Full Text] [Related]
28. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
29. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
Basnet A; Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jahng Y; Na Y; Cho WJ; Kwon Y; Lee CS; Lee ES
Bioorg Med Chem Lett; 2010 Jan; 20(1):42-7. PubMed ID: 19954977
[TBL] [Abstract][Full Text] [Related]
30. Cyanoacetic acid hydrazones of 3-(and 4-)acetylpyridine and some derived ring systems as potential antitumor and anti-HCV agents.
El-Hawash SA; Abdel Wahab AE; El-Demellawy MA
Arch Pharm (Weinheim); 2006 Jan; 339(1):14-23. PubMed ID: 16411172
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
32. Activity of nitrogen-containing and non-nitrogen-containing bisphosphonates on tumor cell lines.
Zhang Y; Leon A; Song Y; Studer D; Haase C; Koscielski LA; Oldfield E
J Med Chem; 2006 Sep; 49(19):5804-14. PubMed ID: 16970405
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents.
Cocco MT; Congiu C; Lilliu V; Onnis V
Bioorg Med Chem Lett; 2004 Dec; 14(23):5787-91. PubMed ID: 15501041
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES
Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N'-substituted ureas with pharmacophoric moieties.
Luzina EL; Popov AV
Eur J Med Chem; 2012 Jul; 53():364-73. PubMed ID: 22538016
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
[TBL] [Abstract][Full Text] [Related]
38. Anticancer activities of some newly synthesized pyridine, pyrane, and pyrimidine derivatives.
Amr AG; Mohamed AM; Mohamed SF; Abdel-Hafez NA; Hammam Ael-F
Bioorg Med Chem; 2006 Aug; 14(16):5481-8. PubMed ID: 16713269
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and biological evaluation of alcyopterosin A and illudalane derivatives as anticancer agents.
Finkielsztein LM; Bruno AM; Renou SG; Moltrasio Iglesias GY
Bioorg Med Chem; 2006 Mar; 14(6):1863-70. PubMed ID: 16321541
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro antitumoral activity of new 3,5-dicyanopyridine derivatives.
Cocco MT; Congiu C; Lilliu V; Onnis V
Bioorg Med Chem; 2007 Feb; 15(4):1859-67. PubMed ID: 17142048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
